Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Leadership Transition Arrangements In connection with the Company’s previously announced appointment of Soraya Benchikh as Chief Financial Officer, Laurent Mercier ceased serving as Chief Financial Officer on September 1, 2026 and commenced se…
Founded in Paris in 1904, Coty is one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care. Coty serves consumers around the world, selling prestige and mass market products in over 120 countries and territories. Coty and our brands empower people to express themselves freely, creating their own visions of beauty; and we are committed to protecting the planet.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Leadership Transition Arrangements
In connection with the Company’s previously announced appointment of Soraya Benchikh as Chief Financial Officer, Laurent Mercier ceased serving as Chief Financial Officer on September 1, 2026 and commenced service as Strategic CEO Advisor through June 30, 2027 (the “Transition End Date”). In connection with his transition, the Company and Mr. Mercier entered into an agreement governing the terms of his employment through the Transition End Date (the “Transition Agreement”).
Pursuant to the Transition Agreement, Mr. Mercier will continue to receive his annual base salary of €825,000 through the Transition End Date for his advisory services. During September and October 2026, Mr. Mercier will assist with the transition of his responsibilities and, beginning November 1, 2026, will be released from active duties while remaining available to provide transition-related advisory services. At Mr. Mercier’s option, the Transition End Date may be accelerated to a date no earlier than December 20, 2026, in which case he would receive a lump-sum payment equal to the salary otherwise payable through June 30, 2027.
Mr. Mercier will not be eligible for any annual bonus or variable compensation with respect to fiscal years 2026 or 2027 other than a fixed one-time bonus of €290,000. Equity awards scheduled to vest in October 2026 will remain eligible to vest in accordance with their terms, and any equity awards that remain unvested after the Transition End Date will be forfeited. Following the Transition End Date, Mr. Mercier will be subject to a twelve-month non-competition covenant and will be entitled to receive the related contractual non-competition payments. Mr. Mercier also will be entitled to receive applicable contractual and collective bargaining severance benefits.
The foregoing description is qualified in its entirety by reference to the Transition Agreement, which will be filed as an exhibit to the Company’s Form 10-Q for the period ending September 30, 2026.